Evaluating the feasibility and efficacy of a dual-modality nanoparticle contrast agent (Nanotrast-CF800) for image-guided sentinel lymph node mapping in the oral cavity of healthy dogs
J. Wan, M. L. Oblak, A. S. Ram, C. McKenna, A. Singh, S. Nykamp
This study evaluates a nanoparticle contrast agent for sentinel lymph node mapping in dogs, showing it effectively identifies SLNs with no adverse effects.
bioRxiv · Jul 26, 2021Cancer Biology